TScan Therapeutics, Inc. TCRX Q3 2025 earnings

FAQ

When did TScan Therapeutics, Inc. report Q3 2025 earnings?

TScan Therapeutics, Inc. (TCRX) reported Q3 2025 earnings on November 12, 2025 before market open.

What were TScan Therapeutics, Inc.'s Q3 2025 revenue and EPS?

TScan Therapeutics, Inc. reported revenue of $2.5M and eps of $-0.28 for Q3 2025.

Did TScan Therapeutics, Inc. beat estimates in Q3 2025?

Revenue beat the consensus estimate of $1.9M by $571.0K. EPS beat the consensus estimate of $-0.35 by $0.07.

How did TScan Therapeutics, Inc.'s Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 139.4% from $1.0M a year earlier and eps declined 12.0% from $-0.25.

Where can I find TScan Therapeutics, Inc.'s Q3 2025 SEC filings?

You can read the 8-K earnings release (0001193125-25-275889) and the 10-Q periodic report (0001193125-25-275933) directly on SEC EDGAR. The filing index links above go to sec.gov.